163 related articles for article (PubMed ID: 36805784)
21. Proton beam therapy for skull base chordomas: a systematic review of tumor control rates and survival rates.
Pahwa B; Medani K; Lu VM; Elarjani T
Neurosurg Rev; 2022 Dec; 45(6):3551-3563. PubMed ID: 36181614
[TBL] [Abstract][Full Text] [Related]
22. Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis.
Ng WT; But B; Wong CHL; Choi CW; Chua MLK; Blanchard P; Lee AWM
Clin Transl Radiat Oncol; 2022 Nov; 37():41-56. PubMed ID: 36065359
[TBL] [Abstract][Full Text] [Related]
23. Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi-institutional study in Japan.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Med; 2018 May; 7(5):1870-1874. PubMed ID: 29605967
[TBL] [Abstract][Full Text] [Related]
24. Skin Toxicity Profile of Photon Radiotherapy versus Proton Beam Therapy in Paediatric and Young Adult Patients with Sarcomas.
Gaito S; Abravan A; Richardson J; Lowe M; Indelicato DJ; Burnet N; Smith E
Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):507-516. PubMed ID: 33820695
[TBL] [Abstract][Full Text] [Related]
25. Particle beam radiation therapy for sinonasal malignancies: Single institutional experience at the Shanghai Proton and Heavy Ion Center.
Hu W; Hu J; Huang Q; Gao J; Yang J; Qiu X; Kong L; Lu JJ
Cancer Med; 2020 Nov; 9(21):7914-7924. PubMed ID: 32977357
[TBL] [Abstract][Full Text] [Related]
26. Tailor-made treatment combined with proton beam therapy for children with genitourinary/pelvic rhabdomyosarcoma.
Fukushima H; Fukushima T; Sakai A; Suzuki R; Kobayashi C; Oshiro Y; Mizumoto M; Hoshino N; Gotoh C; Urita Y; Komuro H; Kaneko M; Sekido N; Masumoto K; Sakurai H; Sumazaki R
Rep Pract Oncol Radiother; 2015; 20(3):217-22. PubMed ID: 25949226
[TBL] [Abstract][Full Text] [Related]
27. Outcome and Patterns of Relapse in Childhood Parameningeal Rhabdomyosarcoma Treated With Proton Beam Therapy.
Doyen J; Jazmati D; Geismar D; Frisch S; Schleithoff SS; Vermeren X; Scheer M; Blase C; Tippelt S; Timmermann B
Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):1043-1054. PubMed ID: 31419513
[TBL] [Abstract][Full Text] [Related]
28. Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
Indelicato DJ; Rotondo RL; Krasin MJ; Mailhot Vega RB; Uezono H; Bradfield S; Agarwal V; Morris CG; Bradley JA
Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):968-976. PubMed ID: 31987977
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
30. Proton therapy for pediatric head and neck malignancies.
Vogel J; Both S; Kirk M; Chao HH; Bagatell R; Li Y; Womer R; Balamuth N; Reilly A; Kurtz G; Lustig R; Tochner Z; Hill-Kayser C
Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 29058370
[TBL] [Abstract][Full Text] [Related]
31. High-dose proton beam therapy for stage I non-small cell lung cancer: Clinical outcomes and prognostic factors.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Azami Y; Kato T; Tsukiyama I; Hareyama M; Kikuchi Y; Daimon T; Hata M; Inoue T; Fuwa N
Acta Oncol; 2015 Mar; 54(3):307-14. PubMed ID: 25291076
[TBL] [Abstract][Full Text] [Related]
32. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects.
Childs SK; Kozak KR; Friedmann AM; Yeap BY; Adams J; MacDonald SM; Liebsch NJ; Tarbell NJ; Yock TI
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):635-42. PubMed ID: 21377294
[TBL] [Abstract][Full Text] [Related]
33. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
[TBL] [Abstract][Full Text] [Related]
34. Pencil Beam Scanning Proton Therapy for Pediatric Parameningeal Rhabdomyosarcomas: Clinical Outcome of Patients Treated at the Paul Scherrer Institute.
Weber DC; Ares C; Albertini F; Frei-Welte M; Niggli FK; Schneider R; Lomax AJ
Pediatr Blood Cancer; 2016 Oct; 63(10):1731-6. PubMed ID: 26701148
[TBL] [Abstract][Full Text] [Related]
35. Charged particle therapy for high-grade gliomas in adults: a systematic review.
Wang Y; Liu R; Zhang Q; Dong M; Wang D; Chen J; Ou Y; Luo H; Yang K; Wang X
Radiat Oncol; 2023 Feb; 18(1):29. PubMed ID: 36755321
[TBL] [Abstract][Full Text] [Related]
36. Proton beam therapy for pediatric malignancies: a retrospective observational multicenter study in Japan.
Mizumoto M; Murayama S; Akimoto T; Demizu Y; Fukushima T; Ishida Y; Oshiro Y; Numajiri H; Fuji H; Okumura T; Shirato H; Sakurai H
Cancer Med; 2016 Jul; 5(7):1519-25. PubMed ID: 27165972
[TBL] [Abstract][Full Text] [Related]
37. Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer.
Kim TH; Lee KS; Sim SH; Kim YJ; Kim DY; Chae H; Lee EG; Han JH; Jung SY; Lee S; Kang HS; Lee ES
Front Oncol; 2021; 11():783327. PubMed ID: 34804986
[TBL] [Abstract][Full Text] [Related]
38. Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Badiyan SN; Rutenberg MS; Hoppe BS; Mohindra P; Larson G; Hartsell WF; Tsai H; Zeng J; Rengan R; Glass E; Katz S; Vargas C; Feigenberg SJ; Simone CB
Pract Radiat Oncol; 2019; 9(4):280-288. PubMed ID: 30802618
[TBL] [Abstract][Full Text] [Related]
39. Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma.
Kim TH; Woo SM; Lee WJ; Chun JW; Cho YR; Kim BH; Koh YH; Kim SS; Oh ES; Lee DY; Lee SU; Suh YG; Moon SH; Park JW
Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428654
[TBL] [Abstract][Full Text] [Related]
40. Toxicity profile of patients treated with proton and carbon-ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta-analysis.
Yahya N; Mohamad Salleh SA; Mohd Nasir NF; Abdul Manan H
Asia Pac J Clin Oncol; 2024 Apr; 20(2):240-250. PubMed ID: 36683266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
